tweetindex
TR

Cancer Research Institute

@CancerResearch · New York, NY, USA · joined 26 Apr 2008

Advancing cancer immunotherapy through research, collaboration and data-driven innovation. Creating a world #Immune2Cancer. Est. 1953.

30 591Followers
4 569Following
27 078Posts total
3.3KViews on collected posts

Son gönderiler

Before cancer develops. Before it takes hold. Before it returns. Researchers are exploring 3 windows to act: 1️⃣ Primary prevention 2️⃣ Cancer interception 3️⃣ Preventing recurrence Explore how science is creating new opportunities to intervene: https://t.co/DPaP9SrPZh https:/
556 views · 5 likes · 1 reposts · 1 replies Open on X →
What makes ovarian cancer difficult to detect early? Symptoms like bloating, pelvic pain, feeling full quickly & urinary changes can be easy to overlook. This #OvarianCancerAwarenessMonth, explore how immunotherapy is advancing treatment: https://t.co/MqwBZAecm0 https://t.co/x9
471 views · 0 likes · 1 reposts · 0 replies Open on X →
In FY 2025–26, CRI made its largest grantmaking investment to date: $34.4 million in new funding supporting 93 awards across 50 institutions, 17 U.S. states, and five countries. Explore: https://t.co/jK2p8kLWQZ https://t.co/bR1vfPyDVa
768 views · 12 likes · 1 reposts · 0 replies Open on X →
Once considered a disease of older adults who smoke, the rise of lung cancer in nonsmokers and young adults is an alarming trend. #LCINS is now recognized as a distinct disease entity that is biologically different from lung cancer caused by smoking: https://t.co/ZfD7OOw1Z6 704 views · 4 likes · 0 reposts · 0 replies Open on X →
What causes sarcoma, and what are the symptoms? Can sarcoma be prevented, or detected early? Discover: https://t.co/SFEkUpfV0o #Immunotherapy #Sarcoma 761 views · 6 likes · 0 reposts · 0 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 5 gönderi, 10K–100K takipçi aralığıyla yan yana. hem erişimde hem etkileşimde benzerlerinin altında.

Medyan görüntülenme704bu hesap94910K–100K için medyan
Erişim, %2.30%bu hesap3.31%10K–100K için medyan
Etkileşim, %0.79%bu hesap1.88%10K–100K için medyan
ÖlçütBu hesap10K–100K için medyanOran
Gönderi başına medyan görüntülenme7049490.74×
Erişim (görüntülenme ÷ takipçi)2.30%3.31%0.70×
Etkileşim oranı0.79%1.88%0.42×

Bu aralıktaki diğer hesaplar →   Başka bir hesapla karşılaştır →   Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

76131 Aug
7042 Sep
7688 Sep
4719 Sep
55610 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.79%31 Aug
0.57%2 Sep
1.69%8 Sep
0.21%9 Sep
1.26%10 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.88%.

What the audience does

Likes77.1%27 in total
Reposts8.6%3 in total
Replies2.9%1 in total
Bookmarks11.4%4 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Benzer hesaplar